TLCVision Secures Extension of Credit Facility Limited Waiver to September 30, 2009
September 10 2009 - 6:29PM
Marketwired
TLC Vision Corporation (NASDAQ: TLCV) (TSX: TLC), North America's
premier eye care services company, today announced that it has
secured from its lenders holding a majority amount of its secured
credit facility, an extension to September 30, 2009 of the
previously announced limited waiver and forbearance with respect to
its credit facility that was set to expire on September 9, 2009.
The credit agreement, dated June 21, 2007, as amended, provides
for a US$85 million term loan and a US$25 million revolving credit
line. As of August 31, 2009, the principal amount outstanding under
the credit facility was US$100.1 million.
The extension and forbearance agreement is contained in an
amendment to the limited waiver no. 4 and amendment no. 5 to the
credit agreement, dated as of September 8, 2009, which, among other
things, provides a limited waiver through September 30, 2009 of
specified defaults and provides that the lenders will, until
October 1, 2009, forbear from exercising their rights arising out
of the non-payment of certain principal, interest and other
payments previously due. The agreement also provides for the
Company to negotiate in good faith and use its best efforts to
agree by September 28, 2009 to (i) a term sheet reflecting terms of
proposed additional financing acceptable to lenders representing a
majority of the outstanding debt under the credit agreement, and
(ii) a term sheet reflecting terms of a debt and/or equity
restructuring acceptable to those lenders required to approve such
debt and/or equity restructuring under applicable law. A copy of
the amendment to the limited waiver no. 4 and amendment no. 5 to
the credit agreement will be included as an exhibit to a Form 8-K
to be filed promptly by the Company.
Forward-Looking Statements
This press release contains certain forward-looking statements
within the meaning of Section 27A of the U.S. Securities Act of
1933, Section 21E of the U.S. Securities Exchange Act of 1934 and
Canadian Provincial Securities Laws, which statements can be
identified by the use of forward-looking terminology, such as
"may," "will," "expect," "intend," "anticipate," "estimate,"
"predict," "plans" or "continue" or the negative thereof or other
variations thereon or comparable terminology referring to future
events or results. We caution that all forward-looking information
is inherently uncertain and that actual results may differ
materially from the assumptions, estimates or expectations
reflected in the forward-looking information. A number of factors
could cause actual results to differ materially from those in
forward-looking statements, including but not limited to economic
conditions, the level of competitive intensity for laser vision
correction, the market acceptance of laser vision correction,
concerns about potential side effects and long term effects of
laser vision correction, the ability to maintain agreements with
doctors on satisfactory terms, quarterly fluctuation of operating
results that make financial forecasting difficult, the volatility
of the market price of our common shares, profitability of
investments, successful execution of our direct-to-consumer
marketing programs, the ability to open new centers, the reliance
on key personnel, medical malpractice claims and the ability to
maintain adequate insurance therefore, claims for federal, state
and local taxes, compliance with industry regulation, compliance
with U.S. and Canadian healthcare regulations, disputes regarding
intellectual property, many of which are beyond our control.
Therefore, should one or more of theses risks materialize, or
should assumptions underlying the forward-looking statements prove
incorrect, actual results may vary significantly from what we
currently foresee. Accordingly, we warn investors to exercise
caution when considering any such forward-looking information
herein and to not place undue reliance on such statements and
assumptions. We are under no obligation (and we expressly disclaim
any such obligation) to update or alter any forward-looking
statements or assumptions whether as a result of new information,
future events or otherwise, except as required by law.
See the Company's reports filed with the Canadian Securities
Regulators and the U.S. Securities and Exchange Commission from
time to time for cautionary statements identifying important
factors with respect to such forward-looking statements, including
certain risks and uncertainties, that could cause actual results to
differ materially from results referred to in forward-looking
statements. TLCVision assumes no obligation to update the
information contained in this press release.
About TLCVision
TLCVision is North America's premier eye care services company,
providing eye doctors with the tools and technologies needed to
deliver high-quality patient care. Through its centers' management,
technology access service models, extensive optometric
relationships, direct to consumer advertising and managed care
contracting strength, TLCVision maintains leading positions in
Refractive, Cataract and Eye Care markets. Information about vision
correction surgery can be found on the TLC Laser Eye Centers'
website at www.lasik.com. More information about TLCVision can be
found on the Company's website at www.tlcv.com.
Contact: James J. Hyland VP Investor Relations (636) 534-2369
Email: investor.relations@tlcvision.com
Tlc Vision (MM) (NASDAQ:TLCV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tlc Vision (MM) (NASDAQ:TLCV)
Historical Stock Chart
From Sep 2023 to Sep 2024